Inventor · disambiguated record
Daniel Vitt
Also filed as: VITT DANIEL
13 granted patents·13 pending applications·49 citations·filing 2000–2024
88Inventor score
Top patents by PatentIndex Score
26 records- 0190US11376232B2Vidofludimus for use in the treatment or prevention of viral diseasesIMMUNIC AG·Filed 2021·Granted Jul 5, 2022·2 cites·29 claims
- 0287US11877994B2Treatment of multiple sclerosis comprising DHODH inhibitorsIMMUNIC AG·Filed 2021·Granted Jan 23, 2024·1 cites·18 claims
- 0383US8354433B2Anti-inflammatory agents as virostatic compounds4SC AG·Filed 2010·Granted Jan 15, 2013·12 cites·24 claims
- 0482US9951050B2Method of inhibiting DYRK1B4SC DISCOVERY GMBH·Filed 2014·Granted Apr 24, 2018·7 cites·18 claims
- 0582US8207174B2Aryloxypropanolamines, methods of preparation therof and use of aryloxypropanolamines as medicamentsTASLER STEFAN·Filed 2008·Granted Jun 26, 2012·20 cites·31 claims
- 0681US12433860B2Treatment of multiple sclerosis comprising DHODH inhibitorsIMMUNIC AG·Filed 2023·Granted Oct 7, 2025·0 cites·18 claims
- 0779US2025120931A1Treatment of multiple schlerosis comprising dhodh inhibitorsIMMUNIC AG·Filed 2024·Application pending·0 cites
- 0875US11877995B2Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseasesIMMUNIC AG·Filed 2022·Granted Jan 23, 2024·0 cites·34 claims
- 0973US2024100005A1Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune DiseasesIMMUNIC AG·Filed 2023·Application pending·0 cites
- 1071US8653138B2Calcium salts of compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agentsAMMENDOLA ALDO·Filed 2011·Granted Feb 18, 2014·5 cites·19 claims
- 1167US12167994B2Vidofludimus for use in the treatment or prevention of viral diseasesIMMUNIC AG·Filed 2022·Granted Dec 17, 2024·0 cites·19 claims
- 1265US6727100B1Method of identifying candidate molecules4SC AG·Filed 2000·Granted Apr 27, 2004·2 cites·27 claims
- 1364US2025136542A1Calcium salt polymorphs as anti-inflammatory, immunodulatory and anti-proliferative agentsIMMUNIC AG·Filed 2024·Application pending·0 cites
- 1463US12037305B2Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agentsIMMUNIC AG·Filed 2019·Granted Jul 16, 2024·0 cites·16 claims
- 1563US2024335405A1Vidofludimus and related structures acting as nurr1 agonistsIMMUNIC AG·Filed 2024·Application pending·0 cites
- 1662US2025243190A1New deuterated rorgamma/rorgammat inverse agonistsIMMUNIC AG·Filed 2023·Application pending·0 cites
- 1760US2025066290A1Dhodh inhibitors containing a carboxylic acid bioisostereIMMUNIC AG·Filed 2022·Application pending·0 cites
- 1860US2025032527A1Medical use of n4-hydroxy citicoline compoundsIMMUNIC AG·Filed 2022·Application pending·0 cites
- 1958US2024368145A1Methods for treating cancerIMMUNIC AG·Filed 2022·Application pending·0 cites
- 2057US10633369B2Method of inhibiting DYRK1B4 SC AG·Filed 2018·Granted Apr 28, 2020·0 cites·14 claims
- 2157US2024199535A1Deuterated dhodh inhibitorsIMMUNIC AG·Filed 2022·Application pending·0 cites
- 2254US2020360324A1Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune DiseasesIMMUNIC AG·Filed 2018·Application pending·0 cites
- 2347US2002197610A1Method and system of identifying biologically active moleculesFiled 2001·Application pending·0 cites
- 2447US2003003456A1Method and system of identifying biologically active moleculesFiled 2001·Application pending·0 cites
- 2545US2007219190A1Heterocyclic NF-kB Inhibitors4SC AG·Filed 2007·Application pending·0 cites
- 2641US11292788B2IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chronic inflammationIMMUNIC AG·Filed 2018·Granted Apr 5, 2022·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Daniel Vitt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →